INTRODUCTION: Laparoscopic greater curvature plication (LGCP) is a novel restrictive technique that reduces gastric volume by plication of the greater curvature. The advantage of LGCP is its reversibility in comparison to laparoscopic sleeve gastrectomy. Nowadays, the long-term LGCP efficacy, safety and metabolic effect are being investigated. AIM: To assess body composition, clinical complications and metabolic changes in obese patients 6 and 12 months after laparoscopic greater curvature plication. MATERIAL AND METHODS: A total of 70 subjects underwent LGCP; 52 of them (33 women and 19 men) completed 1-year follow-up study. Anthropometry and biochemical parameters (glucose, glycated haemoglobin, lipids, ghrelin, leptin, adiponectin and fibroblast growth factor 21 [FGF-21]) were assessed before and 3, 6, and 12 months after surgery. RESULTS: All study participants exhibited statistically significant weight loss at both 6 and 12 months following the LGCP compared to baseline, with significant reductions in body composition - body weight, body mass index, percentage excess weight loss (%EWL), and percentage excess BMI loss (%EBL) (p ≤ 0.001). Moreover, significant lowering of glucose and glycated haemoglobin, triacylglycerols and leptin was observed 12 months after LGCP. On the other hand, plasma concentrations of ghrelin, adiponectin and LDL cholesterol increased significantly. Total cholesterol, LDL cholesterol and FGF-21 levels did not change significantly. CONCLUSIONS: Laparoscopic greater curvature plication appears to be a procedure with good restriction results, which might be mediated through alteration in incretin metabolism. Technical aspects and standardization of the procedure still remain to be worked out.

Department of Biomedical Sciences Faculty of Medicine University of Ostrava Czech Republic

Department of Physiology and Pathophysiology University of Ostrava Ostrava Czech Republic

Department of Surgical Studies Faculty of Medicine University of Ostrava Ostrava Czech Republic

Zobrazit více v PubMed

Walpole SC, Prieto-Merino D, Edwards P, et al. The weight of nations: an estimation of adult human biomass. BMC Public Health. 2012;12:439. PubMed PMC

Matoulek M, Svačina Š, Lajka J. The incidence of obesity and its complications in the Czech Republic. Vnitrni Lekarstvi. 2010;56:1019–27. PubMed

Dadan J, Iwacewicz P, Hady HR. New approaches in bariatric surgery. Videosurgery Miniinv. 2008;3:66–70.

Stanowski E, Pasnik K. Bariatric surgery – the current state of knowledge. Videosurgery Miniinv. 2008;3:71–86.

Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI < 35 kg/m(2): an integrative review of early studies. Obes Surg. 2010;20:776–90. PubMed

Olbers T, Bjorkman S, Lindroos A, et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-y gastric bypass and laparoscopic vertical banded gastroplasty – a randomized clinical trial. Ann Surg. 2006;244:715–22. PubMed PMC

Buzink S, Soltes M, Radonak J, et al. Laparoscopic surgical skills programme: preliminary evaluation of grade I level 1 courses by trainees. Videosurgery Miniinv. 2012;7:188–92. PubMed PMC

Soltes M, Radonak J. A risk score to predict the difficulty of elective laparoscopic cholecystectomy. Videosurgery Miniinv. 2014;9:608–12. PubMed PMC

Wylezol M, Pasnik K, Dabrowiecki S, et al. Polish recommendations for bariatric surgery. Videosurgery Miniinv. 2009;4:S5–8.

Picot J, Jones J, Colquitt JL, et al. Weight loss surgery for mild to moderate obesity: a systematic review and economic evaluation. Obes Surg. 2012;22:1496–506. PubMed

Shen DJ, Ye H, Wang YD, et al. Comparison of short-term outcomes between laparoscopic greater curvature plication and laparoscopic sleeve gastrectomy. Surg Endosc Other Interv Techn. 2013;27:2768–74. PubMed

Ramos A, Neto MG, Galvao M, et al. Laparoscopic greater curvature plication: initial results of an alternative restrictive bariatric procedure. Obes Surg. 2010;20:913–8. PubMed

Skrekas G, Antiochos K, Stafyla VK. Laparoscopic gastric greater curvature plication: results and complications in a series of 135 patients. Obes Surg. 2011;21:1657–63. PubMed

Lee WJ, Lee KT, Ser KH, et al. Laparoscopic adjustable gastric banding (LAGB) with gastric plication: short-term results and comparison with LAGB alone and sleeve gastrectomy. Surg Obes Relat Dis. 2015;11:125–30. PubMed

Ji Y, Wang YD, Zhu JH, et al. A systematic review of gastric plication for the treatment of obesity. Surg Obes Relat Dis. 2014;10:1226–32. PubMed

Buzga M, Holeczy P, Svagera Z, et al. Effects of sleeve gastrectomy on parameters of lipid and glucose metabolism in obese women – 6 months after operation. Videosurgery Miniinv. 2013;8:22–8. PubMed PMC

Hady HR, Dadan J, Golaszewski P, et al. Impact of laparoscopic sleeve gastrectomy on body mass index, ghrelin, insulin and lipid levels in 100 obese patients. Videosurgery Miniinv. 2012;7:251–9. PubMed PMC

Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37. PubMed

Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc Other Interv Techn. 2010;24:1005–10. PubMed

Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus a randomized controlled trial. Arch Surg. 2011;146:143–8. PubMed

Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–81. PubMed

Buzga M, Machytka E, Klvana P, et al. Effects of the intragastric balloon MedSil (R) on weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance. Obes Surg. 2014;24:909–15. PubMed PMC

Fried M, Yumuk V, Oppert JM, et al. Interdisciplinary European Guidelines on metabolic and bariatric surgery. Obes Surg. 2014;24:42–55. PubMed

Bradnova O, Kyrou I, Hainer V, et al. Laparoscopic greater curvature plication in morbidly obese women with type 2 diabetes: effects on glucose homeostasis, postprandial triglyceridemia and selected gut hormones. Obes Surg. 2014;24:718–26. PubMed

Ivano F, Menacho A, Silva L, et al. Comparison of ghrelin plasma levels between pre and post operatory period in patients submitted to gastric plication associated with fundoplication. Obes Surg. 2013;23:1064–5. PubMed

Gale SM, Castracane VD, Mantzoros CS. Energy homeostasis, obesity and eating disorders: recent advances in endocrinology. J Nutr. 2004;134:295–8. PubMed

Kini S, Herron DM, Yanagisawa RT. Bariatric surgery for morbid obesity – a cure for metabolic syndrome? Med Clin North Am. 2007;91:1255–71. PubMed

Iglesias P, Selgas R, Romero S, et al. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. Eur J Endocrinol. 2012;167:301–9. PubMed

Reinehr T, Woelfle J, Wunsch R, et al. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. J Clin Endocrinol Metabol. 2012;97:2143–50. PubMed

Mraz M, Bartlova M, Lacinova Z, et al. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clin Endocrinol. 2009;71:369–75. PubMed

Mai K, Schwarz F, Bobbert T, et al. Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction. Metabol Clin Exp. 2011;60:306–11. PubMed

Woelnerhanssen B, Peterli R, Steinert RE, et al. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy – a prospective randomized trial. Surg Obes Relat Dis. 2011;7:561–8. PubMed

Haluzikova D, Lacinova Z, Kavalkova P, et al. Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects. Obesity. 2013;21:1335–42. PubMed

Unraveling adipose tissue proteomic landscapes in severe obesity: insights into metabolic complications and potential biomarkers

Proteomic Signatures of Human Visceral and Subcutaneous Adipocytes

The risk of sarcopenia 24 months after bariatric surgery - assessment by dual energy X-ray absorptiometry (DEXA): a prospective study